The present invention relates to a stable liquid formulation of etanercept that efficiently reduces the production of etanercept byproducts, stably maintaining the pharmaceutical efficiency of the medication during long-term storage. The liquid composition of the invention is provided in pre-filled syringes ready for immediate use in areas requiring treatment with etanercept.
展开▼